stock

Abbvie Inc (ABBV)

0

Share

Stay up to date

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. The Company strives to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.

Financial Statements

Key Info

  • Industry: Pharmaceutical Preparation Manufacturing
  • Sector: Manufacturing
  • CEO Name: Richard Gonzalez

Key Statistics

  • Stock Price: $120.78
  • Dividend Yield: 4.1000000000000005%
  • Market Capitalization: $213,068,353,893
  • Shares Outstanding: 1,767,175,532
  • Number of Employees: 2,020
  • Trailing 12-Month EPS: $3.71
  • Trailing 12-Month DPS: $5.0
  • Payout Ratio: 134.8%

Important Dates

  • Next Earnings Date: 2021-10-29
  • Next Ex-Dividend Date: 2021-07-14

Price Trends

  • Current Stock Price: $120.78
  • 52-week high: $121.4
  • 52-week low: $76.4
  • 200-day moving average: $111.3
  • 50-day moving average: $117.3

Performance

  • 1-Month Price Return: 3.7%
  • 3-Month Price Return: 7.7%
  • 6-Month Price Return: 14.5%
  • 1-Year Price Return: 34.4%
  • 2-Year Price Return: 103.3%
  • 5-Year Price Return: 135.8%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast